×
About 21,318 results

ALLMedicine™ Lymphoma Center

Research & Reviews  8,150 results

Association between multimorbidity and socioeconomic deprivation on short-term mortalit...
https://doi.org/10.1136/bmjopen-2021-049087
BMJ Open; Smith MJ, Njagi EN et. al.

Dec 2nd, 2021 - We aimed to assess the association between multimorbidity and deprivation on short-term mortality among patients with diffuse large B-cell (DLBCL) and follicular lymphoma (FL) in England. The association of multimorbidity and socioeconomic depriva...

Atypical presentation of plasmablastic lymphoma in immunocompetent patient.
https://doi.org/10.1136/bcr-2021-243310
BMJ Case Reports; Khan MD, Natarajan S et. al.

Dec 2nd, 2021 - Plasmablastic lymphoma (PBL) is an uncommon and aggressive type of mature B cell lymphoma rarely involving gastrointestinal (GI) tract. Here, we describe a case of PBL involving the colon in HIV/Epstein-Barr virus negative immunocompetent patient ...

Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retros...
https://doi.org/10.1016/j.clml.2021.10.018
Clinical Lymphoma, Myeloma & Leukemia; Bennani NN, Tun AM et. al.

Dec 2nd, 2021 - Extranodal natural killer/T-cell lymphoma (ENKTL) is rare and clinical data from non-Asian countries are lacking. It is unclear whether outcomes and disease natural history is similar to reported Asian series. We assessed characteristics and outco...

see more →

Guidelines  21 results

UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic La...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894347
British Journal of Haematology; Turton P, El-Sharkawi D et. al.

Nov 23rd, 2020 - Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell non-Hodgkin Lymphoma (NHL) associated with breast implants. Raising awareness of the possibility of BIA-ALCL in anyone with breast implants and new breast sy...

Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Gu...
https://doi.org/10.6004/jnccn.2020.0036
Journal of the National Comprehensive Cancer Network : JN... Davies K, Barth M et. al.

Aug 7th, 2020 - Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the tre...

Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anap...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106983
Journal of Clinical Oncology : Official Journal of the Am... Jaffe ES, Ashar BS et. al.

Feb 12th, 2020 - To provide guidelines for the accurate pathologic diagnosis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), the preoperative evaluation of the patient with suspected BIA-ALCL, and the pathologic evaluation of the capsulecto...

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical ...
https://doi.org/10.6004/jnccn.2020.0006
Journal of the National Comprehensive Cancer Network : JN... Wierda WG, Byrd JC et. al.

Feb 6th, 2020 - Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are characterized by a progressive accumulation of leukemic cells in the peripheral blood, bone marrow, and lymphoid tissues. Treatment of CLL/SLL has evolved significantly in...

see more →

Drugs  65 results see all →

News  287 results

Fast Five Quiz: Management of Mantle Cell Lymphoma
https://reference.medscape.com/viewarticle/960654

Nov 17th, 2021 - Mantle cell lymphoma (MCL) is a rare subtype of B-cell non-Hodgkin lymphomas. As with many other B-cell malignancies, MCL comprises a wide variety of biological and clinical variants. Consequently, its diagnosis can be challenging. The disease cou...

Ibrutinib Add-on 'Almost Certainly' Saves Lives in DLBCL
https://www.medscape.com/viewarticle/962580

Nov 9th, 2021 - The 3-year event-free survival was 100% when ibrutinib (Imbruvica) was added to standard treatment for two genetic subtypes of diffuse large B-cell lymphoma (DLBCL) among patients age 60 years or younger, according to National Cancer Institute inv...

Younger Non-Hodgkin Lymphoma Survivors at Higher Risk for Age-Related Diseases
https://www.medscape.com/viewarticle/962285

Nov 8th, 2021 - NEW YORK (Reuters Health) - Younger survivors of B-cell non-Hodgkin's lymphoma (B-NHL) have a higher risk of developing acute renal failure, and possibly pneumonia and nutritional deficiencies, than their older peers, new research suggests. "Thank...

Fast Five Quiz: Test Your Knowledge of Mantle Cell Lymphoma
https://www.medscape.com/viewarticle/879288

Nov 8th, 2021 - Mantle cell lymphoma (MCL) is a lymphoproliferative disorder derived from a subset of naive pregerminal center cells localized in primary follicles or in the mantle region of secondary follicles. MCL was not recognized by previous lymphoma classif...

New Trials in Lymphoma and MM: Could Your Patient Benefit?
https://www.medscape.com/viewarticle/962201

Nov 3rd, 2021 - A number of late-phase clinical trials in lymphoma and multiple myeloma (MM) have opened in recent months. Maybe one of your patients could benefit from being enrolled? Untreated peripheral T-cell lymphoma. Adult patients with peripheral T-cell ly...

see more →

Patient Education  4 results see all →